Orgenesis Profile

0.25
USD 0.02  7.41%
0.25Last Month High 0.44 
0.23Trading Day  High 0.29 

Selected Orgenesis Inc Income Statement Over Time

Consolidated Income    Earning Before Interest and Taxes EBIT    Net Income    

Key Fundamentals

Orgenesis Against Markets

Orgenesis Inc., a biopharmaceutical company, develops transdifferentiation technologies in the field of cell therapy and regenerative medicine. more
Fama & French Pharmaceutical Products
Pharmaceutical Products
Fama & French Classification
NameOrgenesis Inc
Macroaxis Advice
InstrumentUSA Stock Stocks Directory
LocationMARYLAND, U.S.A
Business AddressGermantown, MD
ExchangeOTC Market
CUSIP68619K105
IndustryPharmaceutical Products
BenchmarkDOW
Websitewww.orgenesis.com
Contact Number480 659 6404
Related EntityBOUT
CurrencyUSD - US Dollar

Directors

Orgenesis Corporate Directors
David Sidransky Director
Yaron Adler Director
Marie Bouillez Director

Opportunities

Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Investing Ideas